Endocrine Society Calls for Negotiated Insulin Prices in Medicare
January 13th 2021, 9:17pm
ArticleThe statement is aimed at drug companies, policymakers, pharmacy benefit managers, employers, and others, and calls to attention soaring insulin costs, which were the subject of several Congressional hearings in 2019.